Clinical / Pharmaceutical

Pentosan Polysulfate

Elmiron · PPS · SP-54 · Cartrophen

Pentosan Polysulfate (Elmiron) is a highly specialized, semi-synthetic heparinoid structurally similar to the body’s natural mucosal lining. Remaining the only FDA-approved oral weapon against the excruciating pelvic pain of Interstitial Cystitis (IC), it is deployed to literally spackle over and repair profound acid burns within the bladder wall. Additionally, in elite veterinary medicine (Cartrophen), it is injected to massively halt severe arthritic joint degradation.

Not FDA-approved - research chemical
Reviewed by CalcMyPeptide Editorial Team
Last updated: August 2026Evidence: High1 peer-reviewed citation
Typical research dose
100 mg 3× daily (oral) or 2 mg/kg IM
Frequency
3× daily (oral) or 1-2× weekly (IM)
Half-life
~4.8 hours (oral); longer intramuscular
Common vials
N/A (oral)
CAS
37319-17-8
Molecular weight
4000–6000 Da (variable polysaccharide)

Use-case scores

0–10 against the evidence we have, not a gym ranking. Hidden domains do not apply here.

  • Injury & tissue4/10

    Elmiron is FDA-approved for interstitial cystitis. Pigmentary maculopathy is a serious long-term risk. Haircut from 9 because this leaf is identity, not a urology clinic, and the molecule is not a peptide.

Compound card

Class
Semi-synthetic sulfated xylan (Elmiron; not a peptide)
Formula
C5H8O10SNa (repeating unit - polysaccharide)
Status
Not FDA-approved · research use

How it works

Pentosan Polysulfate Sodium (PPS, Elmiron®) is a semi-synthetic polysaccharide derived from beechwood hemicellulose. While not a traditional peptide, it is frequently researched alongside peptide therapies for musculoskeletal and joint conditions. It acts as a glycosaminoglycan (GAG) analog - coating damaged cartilage surfaces, inhibiting proteolytic enzymes (MMPs), reducing chondrocyte death, and stimulating proteoglycan production. FDA-approved for interstitial cystitis since 1996. Off-label veterinary use for equine and canine osteoarthritis is extensive. Recent research into human joint injection protocols is ongoing.

Source: PMID: 2206774

Research Use Cases

  • ✓Interstitial Cystitis: High
  • ✓Osteoarthritis / Joint Repair: Moderate

Dosing

PhaseDoseFrequencyNotes
Oral (FDA-approved IC)100 mgThree times daily (oral, on empty stomach)Elmiron protocol for interstitial cystitis. 3-6 months to assess response.
IM/SC (Joint Research)1-3 mg/kgOnce or twice weekly (IM)Off-label joint injection research doses (extrapolated from veterinary protocols).

Administration

Route / form
Oral (standard); IM injection (joint research protocols)
Timing
Oral: Empty stomach, 1 hour before or 2 hours after meals.
Empty stomach?
Yes - Empty stomach.

Timeline

Months 1-3
Reduction in bladder pain/frequency (IC indication). Joint symptom reduction begins.
Months 6+
Cartilage degradation slowing in OA models. Peak IC benefit.

Who it is for

Interstitial Cystitis

High

FDA-approved (Elmiron). First-line oral pharmacological treatment for IC.

Osteoarthritis / Joint Repair

Moderate

GAG-mimetic cartilage protection. Extensive veterinary evidence; human OA trials ongoing.

Safety & Considerations

FDA-approved orally (Elmiron). IMPORTANT: Retinal pigmentary maculopathy linked to chronic high-dose use (>1-3 years). Annual retinal screening recommended for long-term users. Rare aplastic anemia at high doses.

Regulatory & Legal Status

FDA Status (US)
Research Only
WADA Status (2026)
Not Listed

Not currently on the WADA 2026 Prohibited List. Policies may change - verify before competition.

Classification

Research Chemical

US Compounding: Not eligible / not available

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.

Limits of current evidence

  • Maculopathy monitoring is on the adult file.
  • This site will not treat IC or osteoarthritis from a PPS page.

Verdict

PPS is Elmiron, a polysaccharide, not a peptide. IC label is real. Eye toxicity is real. Joint-injection folklore is not that label.

Interactions & Contraindications

FDA-approved orally (Elmiron). IMPORTANT: Retinal pigmentary maculopathy linked to chronic high-dose use (>1-3 years). Annual retinal screening recommended for long-term users. Rare aplastic anemia at high doses.

Frequently Asked Questions

Is pentosan polysulfate safe for long-term use?▼
FDA-approved pentosan polysulfate (Elmiron) has rare but serious maculopathy risk with long-term use. Annual ophthalmological retinal screening is now recommended for all patients on Elmiron for more than 3 years.
Does pentosan polysulfate work for osteoarthritis?▼
In animal models and limited human trials, injectable PPS reduces cartilage degradation markers and improves joint symptoms. It is not FDA-approved for OA in the US but is used off-label in veterinary medicine extensively.

References

  1. Ghosh P, Smith M “"Pentosan polysulfate sodium for OA: review of evidence".” Current Therapeutic Research (2019).

Looking for a trusted source? See our recommended suppliers

Independently tested · COA-verified · Save 10% with our exclusive code

See suppliers →